EX-99.1 3 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1

EXHIBIT 99.1

 

For Immediate Release

Contact:  Shawn M. Harrington

March 9, 2004

(860) 644-1551

 

GERBER SCIENTIFIC ANNOUNCES FISCAL 2004 THIRD QUARTER RESULTS

 

SOUTH WINDSOR, CT -- Gerber Scientific, Inc. (NYSE: GRB) today reported a net loss of $0.05 per diluted share on revenue of $120.9 million for the fiscal quarter ended January 31, 2004, compared with net earnings of $0.07 per diluted share on revenue of $122.0 million for the fiscal quarter ended January 31, 2003.

For the nine months ended January 31, 2004, the Company reported net earnings of $0.09 per diluted share on revenue of $380.1 million, compared with net earnings of $0.37 per diluted share on revenue of $376.7 million for the nine months ended January 31, 2003. Excluding a prior year sale of a discontinued operation, net earnings from continuing operations for the nine months ended January 31, 2003 were $0.31 per diluted share.

Foreign currency translation had the effect of increasing revenue by $9.7 million and $28.0 million for the three- and nine-month periods ended January 31, 2004, respectively, versus the prior year comparable periods.

In the fiscal quarter ended January 31, 2004, the Company:

  • Reduced debt $10.8 million to $69.8 million at January 31, 2004. The net debt to capital ratio was 35.0 percent at January 31, 2004, compared with 40.3 percent at October 31, 2003. Net debt is defined as total debt less cash and cash equivalents and capital is defined as net debt plus shareholders' equity.
  • Generated steady operating cash flow of $8.9 million.
  • Experienced significant improvement in the Apparel and Flexible Materials segment for both order entry and revenue, which led to a segment profit of 14.3 percent of sales. Business mix for this segment favored higher margin products and geographic markets.
  • Experienced more significant than usual seasonal decline in Sign Making and Specialty Graphics segment revenue, which was exacerbated by competition from ink jet products, weak European economies, and internal re-engineering initiatives. Recorded incremental accounts receivable, inventory and other asset write-downs totaling $1.1 million.
  • Integrated the Ophthalmic Lens Processing segment's operations into the shared services platform.
  • Vacated a manufacturing facility in accordance with the shared services initiative and recorded a $2.0 million restructuring charge associated with future lease payments.
  • Reduced participant benefit accruals under the Company's defined benefit pension plans, which resulted in a $0.6 million reduction of pension expense.
  • Recorded an income tax benefit of $0.7 million because of a tax legislation change in a foreign jurisdiction.

Commenting on the third quarter results, Marc T. Giles, president and chief executive officer, said "I am pleased with the progress we made in reducing our debt. We repaid $10.8 million in the third quarter and $16.0 million since our refinancing last May. Our ability to generate steady cash flow, even through what has been a period of weak economic demand, is a key strength for our company."

"We experienced a significant improvement in demand for our Apparel and Flexible Materials segment's products both in the United States and in strategic growth markets," said Giles. "Order entry levels haven't been as high in this segment in almost three years. We continued our turnaround efforts in the Spandex business although an unexpectedly severe seasonal decline, weak European economies, competition from ink jet products, and costs associated with our turnaround efforts significantly reduced operating results. Our currency adjusted revenue was significantly below last year's level, offsetting our cost reduction efforts."

Giles concluded, "We previously announced our shared services initiative designed to improve profitability through better supply chain management and the elimination of redundant manufacturing and distribution capacity. In the third quarter, we integrated the operations of the Ophthalmic Lens Processing segment into the shared service platform. Also in the quarter, we vacated a manufacturing facility in the Sign Making and Specialty Graphics segment as part of our consolidation plans. While this action reduced our costs and improves efficiency going forward, it required us to record a $2.0 million restructuring charge in the quarter. I am pleased with the progress made to date on our turnaround initiatives and anticipate benefits going forward."

Fiscal Third Quarter Consolidated Results

Fiscal third quarter revenue and order entry were $120.9 million and $122.3 million, respectively, compared with $122.0 million and $124.4 million for the 2003 fiscal third quarter. Foreign currency translation had the effect of increasing revenue by approximately $9.7 million in the 2004 fiscal third quarter versus the prior year comparable period.

The Company's backlog of orders grew $1.4 million to $33.4 million in the 2004 fiscal third quarter primarily because of increased new orders in the Apparel and Flexible Materials operating segment.

Fiscal third quarter gross margin of 33.6 percent decreased 0.9 percentage points from the 2003 fiscal third quarter. Lower business volume, charges associated with shared services and Spandex re-engineering initiatives, competitive pricing, and a sales mix favoring lower margin products were partially offset by cost reductions implemented during fiscal years 2004 and 2003. Gross margin was also lowered by an improved classification of service costs in the Ophthalmic Lens Processing segment that were previously included in S,G,&A expenses. This improved classification was the result of the transition of that segment's operations to the Company's SAP and shared services platforms on November 1, 2003 and had no impact on operating income.

Consolidated S,G,&A spending in the 2004 fiscal third quarter was lower than in the prior year comparable period. This was the result of cost reduction initiatives implemented during fiscal years 2004 and 2003, lower bonus expense, lower legal and professional costs, and the classification of service costs in the Ophthalmic Lens Processing segment noted above. The effects of these items on S,G,&A spending were partially offset by foreign currency translation, higher current year pension expense, and higher bad debt expense.

To mitigate rising pension costs, the Company amended its defined benefit pension plans, which resulted in reduced participant benefit accruals. These amendments required the plans' measurement at December 31, 2003 using current measurements of both plan assets and obligations. The results of the measurement reduced pension expense by $0.6 million in the 2004 fiscal third quarter from the level originally anticipated.

Restructuring charges of $2.0 million in the 2004 fiscal third quarter were incurred primarily by the Sign Making and Specialty Graphics operating segment. A leased facility was vacated as part of shared services facility consolidations and the operations were relocated to other existing facilities. The restructuring charges represented the net present value of expected future lease payments recorded at the cease-use date of the facility. The Company anticipates that it will incur additional restructuring charges as facility consolidations continue.

Interest expense in the 2004 fiscal third quarter increased $1.0 million over the 2003 fiscal third quarter because of a higher weighted-average interest rate, which was partially offset by lower average debt balances. The weighted-average interest rate increased under the terms of the Company's four-year $110.0 million senior credit facility, which it entered into on May 9, 2003. Consolidated other expense included $0.9 million of foreign currency transaction losses.

In the 2004 fiscal third quarter, the Company recorded a tax benefit of $0.7 million as a result of a change in the tax law of a foreign jurisdiction. Without this tax benefit, the Company's consolidated tax rate from continuing operations would have been 21.0 percent compared to the statutory rate of 35.0 percent. The lower consolidated rate was primarily attributable to benefits related to foreign tax planning strategies and export tax incentives.

Fiscal Third Quarter Segment Results

Segment profit (defined as earnings before interest and taxes - see attached segment information for reconciliation to GAAP measure) for the 2004 fiscal third quarter decreased to $3.9 million from $7.7 million for the 2003 fiscal third quarter.

Sign Making and Specialty Graphics 

The Sign Making and Specialty Graphics segment reported revenue for the 2004 fiscal third quarter of $61.3 million, which represented a decrease of $1.7 million from the 2003 fiscal third quarter. Foreign currency translation had the effect of increasing revenue by $7.0 million in the 2004 fiscal third quarter over the prior year comparable period. Excluding the effects of foreign currency translation, the lower current year revenue occurred largely in Europe and was the result of weak economic conditions, competition from ink jet imaging products, the discontinuation of a product line, and allocation of management resources to the Company's re-engineering efforts, particularly in France and Italy. Segment revenue in the United States was also adversely affected by ink jet competition.

Segment gross margin of 27.7 percent for the 2004 fiscal third quarter decreased 1.1 percentage points from the 2003 fiscal third quarter. The decrease in gross margin was attributable to the lower sales volume, price discounting, and inventory write-downs. The negative impact of these items was partially offset by cost reductions associated with the Company's shared services restructuring initiatives.

The Company experienced segment loss of $2.3 million for the 2004 fiscal third quarter compared to segment profit of $3.2 million for the 2003 fiscal third quarter. Restructuring charges related to the leased facility that was vacated, lower gross margin, higher pension expense, higher bad debt expense, and higher foreign currency transaction losses were partially offset by savings from cost controls and lower bonus expense.

Apparel and Flexible Materials

The Apparel and Flexible Materials segment's revenue increased 9.5 percent, or $3.5 million, to $40.8 million in the 2004 fiscal third quarter over the level achieved in the 2003 fiscal third quarter. Foreign currency translation had the effect of increasing segment revenue by $2.1 million in the third quarter over the prior year comparable period. The overall increase was attributable to improving U.S. economic conditions, particularly in industrial and automotive market segments.

Segment gross margin for the 2004 fiscal third quarter increased 0.6 percentage points to 46.1 percent over the prior year comparable period primarily because of increased volume, a sales mix favoring higher margin products, and cost reductions associated with the Company's shared services restructuring activities.

Segment profit for the 2004 fiscal third quarter increased $2.6 million primarily as a result of improved gross margin, cost reductions associated with shared services, and lower current year bonus expense.

Ophthalmic Lens Processing

The Ophthalmic Lens Processing segment reported revenue for the 2004 fiscal third quarter of $18.8 million, which represented a decrease of $2.9 million from the 2003 fiscal third quarter. The effect of foreign currency translation of $0.6 million was not significant with respect to this segment's results in the current fiscal quarter. The revenue decrease was caused by equipment sales last year to large retail chain customers that did not repeat this year. Business volume was also dampened by the segment's transition to shared services. Excluding the prior year incremental sales, equipment revenue increased over the prior year because of increased capital equipment sales to wholesale optical laboratories.

Segment gross margin for the 2004 fiscal third quarter decreased 6.2 percentage points from the 2003 fiscal third quarter. Improved classification of service costs that were previously included in S,G,&A expenses resulting from the shared services transition, which had no impact on segment profit, represented 6.0 percentage points of the margin decline. Lower sales volume, shared services transition costs, and higher materials cost caused by the weaker U.S. dollar also contributed to the gross margin decrease.

Segment profit for the 2004 fiscal third quarter decreased $0.9 million from the 2003 fiscal third quarter primarily because of the lower sales volume and the shared services transition costs. Cost reductions made in response to the lower sales volume and lower bonus expense partially offset the decrease.

Corporate and Other Expenses

Corporate and other expenses for the 2004 fiscal third quarter decreased to $3.2 million from $4.2 million in the 2003 fiscal third quarter. The positive impact of lower legal and professional expenses and bonus expense was partially offset by higher pension and insurance expense, as well as higher foreign currency transaction losses.

Financial Condition

For the nine months ended January 31, 2004, total debt was reduced by $16.0 million, which was the result of reduced cash balances, operating earnings, and proceeds from the sale of a promissory note in the first quarter.

At January 31, 2004, the Company had $7.2 million in cash and cash equivalents and $69.8 million in total debt. The Company's net debt (defined as total debt less cash and cash equivalents) declined $8.4 million during the third quarter to $62.6 million and the ratio of net debt to capital (defined as the sum of net debt plus shareholders' equity) was 35.0 percent.

The Company was in compliance with all covenants related to its credit facilities as of January 31, 2004. Continued uncertainty in global economic conditions and prolonged weak business environments continue to make estimating demand for the Company's capital equipment products and projecting future results challenging. Although the Company continues to closely monitor compliance with covenants under its credit facilities, failure to be in compliance with any material covenant of the credit facilities could have a material effect on the Company's liquidity, financial position and results of operations.

 

About Gerber Scientific, Inc.

Gerber Scientific, Inc. (http://www.gerberscientific.com) is the world's leading supplier of sophisticated automated manufacturing systems for sign making and specialty graphics, apparel and flexible materials, and ophthalmic lens processing. Headquartered in South Windsor, Connecticut, the Company operates through four businesses: Gerber Scientific Products, Spandex Ltd., Gerber Technology, and Gerber Coburn. 

Safe Harbor Statement:

Statements contained in this news release regarding the Company's expected financial condition, revenue, cash flow, operating results, cost savings, operational efficiencies and other potential benefits of its turnaround initiatives, business strategy and other planned events and expectations are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Actual future results or events may differ from these forward-looking statements. Readers are referred to the documents filed by the Company with the Securities and Exchange Commission, including the Company's annual report on Form 10-K for the fiscal year ended April 30, 2003 and subsequently filed quarterly and current reports, for a discussion of important risks that could cause actual results to differ from those contained or implied in the forward-looking statements. These risks include the following:

  • Delays in new product development and commercialization.
  • Delays in product introductions, product defects or loss of market focus caused by efforts to lower the Company's cost platform.
  • Reliance on manufacturers or suppliers to timely supply parts or aftermarket consumables to the Company's specifications.
  • Fluctuations in currency exchange rates may cause the Company's financial results to decline.
  • Financial and operating covenants associated with the Company's primary credit facilities.
  • Intense competition in each of the Company's operating segments.
  • Ongoing SEC Enforcement Division investigation.
  • Sign shops' transition to lower-cost ink jet imaging systems, calendered vinyls, and digital media systems.
  • Phasing out of trade quotas as of January 1, 2005.
  • Significant, but sometimes non-recurring, orders from key customers.

.

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


Three Months Ended
January 31,

Nine Months Ended
January 31,

             

In thousands (except per share amounts)

2004

 

2003

2004 

 

2003 

             

Revenue:

           

     Product sales

$ 104,518 

 

$ 108,679 

$ 334,954 

 

$ 335,775 

     Service sales

   16,372 

 

   13,324 

   45,178 

 

   40,886 

 120,890 

 122,003 

 380,132 

 376,661 

Costs and Expenses:

           

     Cost of products sold

70,631 

 

72,581 

225,967 

 

223,194 

     Cost of services sold

9,606 

 

7,351 

24,920 

 

21,688 

     Selling, general and administrative

30,547 

 

31,864 

96,294 

 

95,994 

     Research and development

6,021 

 

6,707 

18,647 

 

19,499 

     Restructuring charges

     1,996 

 

      (182)

     2,482 

 

      (282)

 

 118,801 

 

 118,321 

 368,310 

 

 360,093 

Operating income

2,089 

 

3,682 

11,822 

 

16,568 

             

Other expense

(1,355)

 

(133)

(3,508)

 

(1,339)

Interest expense

   (3,013)

 

   (1,977)

   (9,328)

 

   (6,354)

Earnings (loss) from continuing operations
      before income taxes


(2,279)

 


1,572 


(1,014)

 


8,875 

Provision (benefit) for income taxes

    (1,134)

 

       100 

   (2,994)

 

    2,064 

Earnings (loss) from continuing operations

(1,145)

 

1,472 

1,980 

 

6,811 

Discontinued operations:

           

     Income from operations of disposed
         business, net of taxes of $92 in
         fiscal 2003



--- 

 



--- 



--- 

 



172 

     Gain on sale of disposed business, net of
         taxes of $2,244 in fiscal 2003


          --- 

 


        --- 


        --- 

 


  1,222 

Net earnings (loss)

$     (1,145)

 

$   1,472 

$  1,980 

 

$   8,205 

 

=======

 

======

======

 

======

Earnings (loss) per share of common stock:

           

Basic:

           

     Earnings (loss) from continuing operations

$      (.05)

 

$       .07 

$      .09 

 

$       .31 

     Discontinued operations

          --- 

 

        --- 

        --- 

 

       .06 

     Net earnings (loss)

$      (.05)

 

$       .07 

$      .09 

 

$       .37 

 

=======

 

======

======

 

======

             

Diluted:

           

     Earnings (loss) from continuing operations

$      (.05)

 

$       .07 

$      .09 

 

$       .31 

     Discontinued operations

          --- 

 

        --- 

         --- 

 

        .06 

     Net earnings (loss)

$      (.05)

 

$       .07 

$      .09 

 

$       .37 

 

=======

 

======

======

 

======

             

     Dividends

$       ---  

 

$       ---  

$      ---  

 

$       ---  

Average shares outstanding:

           

     Basic

22,205 

 

22,154 

22,190

 

22,134 

     Diluted

22,205 

 

22,270 

22,378

 

22,144 

 

 

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

(Unaudited)


In thousands, except share data

January 31, 2004

 

April 30, 2003

Assets:

     

Current Assets:

     

     Cash and cash equivalents

$    7,224 

 

$    20,697 

Accounts receivable, net of allowance for doubtful
   accounts of $8,392 and $7,277, respectively


87,920 

 


89,657 

     Inventories

54,703 

 

51,982 

     Deferred income taxes

3,740 

 

5,300 

     Prepaid expenses and other current assets

      8,319 

 

     8,327 

 

  161,906 

 

 175,963 

Property, Plant and Equipment

127,134 

 

122,674 

     Less accumulated depreciation

    82,039 

 

   75,309 

 

    45,095 

 

   47,365 

Intangible Assets:

     

     Goodwill

    51,847 

 

    48,912 

     Prepaid pension cost

    5,226 

 

    8,483 

     Patents and other intangible assets, net of accumulated         amortization


      6,241 

 


     6,777 

 

    63,314 

 

   64,172 

Deferred Income Taxes

19,301 

 

14,855 

Other Assets

      8,434 

 

     4,336 

 

$ 298,050 

 

$ 306,691 

 

=======

 

  =======

Liabilities and Shareholders' Equity

     

Current Liabilities:

     

     Current maturities of long-term debt

$     7,611

 

$  14,807 

     Accounts payable

38,905 

 

45,024 

     Accrued compensation and benefits

14,208 

 

23,167 

     Other accrued liabilities

20,604 

 

18,202 

     Deferred revenue

12,388 

 

10,000 

     Advances on sales contracts

     2,242 

 

        945 

 

   95,958 

 

 112,145 

Noncurrent Liabilities:

     

     Accrued pension benefit liability

17,750 

 

23,549 

     Other liabilities

5,666 

 

5,534 

     Long-term debt

   62,210 

 

   71,000 

 

   85,626 

 

  100,083 

Contingencies and Commitments:

     
       

Shareholders' Equity:

     

     Preferred stock, no par value; authorized 10,000,000          shares; no shares issued


--- 

 


--- 

     Common stock, $1.00 par value; authorized 65,000,000          shares; issued 22,935,638 and 22,908,180 shares


 22,936 

 


 22,908 

     Paid-in capital

 43,519 

 

 43,703 

     Retained earnings

 69,892 

 

 67,912 

     Treasury stock, at cost (723,045 and 745,184 shares,          respectively)


(14,868)

 


(15,323)

     Unamortized value of restricted stock grants

(114)

 

(211)

     Accumulated other comprehensive loss

    (4,899)

 

  (24,526)

 

 116,466 

 

   94,463 

 

$ 298,050 

 

$ 306,691 

 

=======

 

=======

 

 

 

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


         Nine Months Ended
          January 31,

       

In thousands

2004

 

2003 

Cash Provided by (Used for):

Operating Activities:

     

     Net earnings

$   1,980 

 

$    8,205 

     Adjustments to reconcile net earnings to cash
        provided by operating activities:

     

           Depreciation and amortization

8,803 

 

9,814 

           Restructuring charges

2,482 

 

(282)

           Gain on sale of disposed business, net of taxes

--- 

 

(1,222)

           Deferred income taxes

(6,129)

 

(477)

           Other non-cash items

2,111 

 

933 

     Changes in operating accounts:

     

           Receivables

6,899 

 

5,571 

           Inventories

1,027 

 

2,873 

           Prepaid expenses

1,029 

 

2,484 

           Accounts payable and accrued expenses

  (9,644)

 

   (9,427)

Provided by Operating Activities

    8,558 

 

   18,472 

Investing Activities:

     

     Additions to property, plant and equipment

(3,056)

 

(1,827)

     Intangible and other assets

(864)

 

(818)

     Proceeds from sale of assets

--- 

 

3,937 

     Proceeds from sale of disposed business

   --- 

   6,595 

     Proceeds from settlement of promissory note

        994 

         --- 

Provided by (Used for) Investing Activities

   (2,926)

 

    7,887 

Financing Activities:

     

     Borrowings under term loans

65,000 

 

3,000 

     Repayments of borrowings under term loans

(88,596)

 

(28,999)

     Net change in revolver

7,611 

 

--- 

     Net short-term financing

    ---  

 

    (254)

     Debt issue costs

(5,604)

 

(1,246)

     Exercise of stock options

114 

 

--- 

     Other common stock activity

          (5)

 

          38 

(Used for) Financing Activities

 (21,480)

 

 (27,461)

Effect of exchange rate changes on cash

2,375 

1,765 

Increase (Decrease) in Cash and Cash Equivalents

(13,473)

 

663 

Cash and Cash Equivalents, Beginning of Period

  20,697 

 

  16,220 

Cash and Cash Equivalents, End of Period

$    7,224 

 

$   16,883 

====== 

====== 

 

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
SEGMENT INFORMATION

(Unaudited)

     


In thousands

Three Months Ended
        January 31,       

Nine Months Ended
January 31,

         

Segment revenue:

   2004   

    2003   

    2004   

    2003   

Sign Making & Specialty Graphics

$   61,291 

$   63,019 

$ 205,604 

$ 198,285 

Apparel & Flexible Materials

40,829 

37,281 

116,814 

113,765 

Ophthalmic Lens Processing

   18,770 

   21,703 

   57,714 

   64,611 

 

$ 120,890 

$ 122,003 

$ 380,132 

$ 376,661 

 

=======

=======

=======

=======

         

Segment profit (loss):

       

Sign Making & Specialty Graphics

$   (2,306)

$    3,224 

$    7,272 

$  13,144 

Apparel & Flexible Materials

5,832 

3,238 

12,983 

10,944 

Ophthalmic Lens Processing

       364 

    1,245 

       715 

    3,952 

 

3,890 

7,707 

20,970 

28,040 

Corporate expenses, net of other      income


(3,156)


(4,158)


(12,656)


(12,811)

Interest expense

    (3,013)

   (1,977)

   (9,328)

   (6,354)

Earnings (loss) from continuing
    operations before income taxes


$   (2,279)


$     1,572 


$    (1,014)


$    8,875 

 

=======

=======

=======

=======

         

Segment profit for the three and nine months ended January 31, 2003 included reversals of previously established restructuring reserves of $0.2 million and $0.3 million, respectively, for the Apparel and Flexible Materials operating segment.

Segment profit for the three months ended January 31, 2004 included restructuring charges of $2.0 million primarily for the Sign Making and Specialty Graphics operating segment. Segment profit for the nine months ended January 31, 2004 included restructuring charges of $2.5 million. Of this amount, $2.1 million was for the Sign Making and Specialty Graphics operating segment and the majority of the remainder of $0.4 million was for the Ophthalmic Lens Processing operating segment.